Mar 15, 2022
Zheng Lab reports new mechanism of breast cancer immune evasion
Breast cancer is one of the leading causes of cancer-related mortality in women.Immunotherapy, especially immune checkpoint inhibitors (ICIs), including PD-1, PD-L1 and CTLA-4 blocking antibodies, has generated remarkable responses in many individuals with solid tumors. However, in breast cancer, especially triple-negative breast cancer (TNBC), limited patients benefit from ICI therapy, indicat...